Fulgent Genetics Q2 2026 Earnings Release
Analysis based on 6 articles · First reported Jul 09, 2026 · Last updated Jul 09, 2026
The announcement is a routine earnings release schedule with no immediate market impact. Investors will watch for Q2 performance and any updates on therapeutic development progress.
Fulgent Genetics, Inc. announced that it will release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will host a conference call at 4:30 PM ET to discuss results. The company is a technology-based laboratory services and therapeutic development firm focused on precision medicine.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard